Smoking Cessation With Varenicline in Schizophrenia
Phase 4
10
about 1.5 years
18–75
1 site in PA
What this study is about
Researchers are testing if stopping smoking with varenicline helps reduce neurological side effects from antipsychotic medications. The trial will involve 10 people with schizophrenia who are smokers and have a condition called tardive dyskinesia while taking antipsychotics. Researchers will monitor changes in smoking status and neurological symptoms over 546 days.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Varenicline
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
varenicline
oral (Oral Tablet)
Psychiatry / Mental Health